| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 53.570 | 70.078 | 72.132 | 84.207 | 101.194 | 113.030 |
| Total Income - EUR | - | - | - | - | 53.578 | 70.087 | 72.136 | 84.210 | 101.202 | 113.038 |
| Total Expenses - EUR | - | - | - | - | 20.232 | 28.693 | 34.082 | 27.622 | 37.349 | 43.689 |
| Gross Profit/Loss - EUR | - | - | - | - | 33.346 | 41.395 | 38.054 | 56.588 | 63.853 | 69.349 |
| Net Profit/Loss - EUR | - | - | - | - | 32.810 | 40.739 | 37.420 | 55.830 | 62.861 | 66.025 |
| Employees | - | - | - | - | 3 | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Dacosmed Ana 2000 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 49.094 | 46.785 | 67.821 | 61.495 | 55.031 |
| Current Assets | - | - | - | - | 36.307 | 30.926 | 32.720 | 32.286 | 31.892 | 24.255 |
| Inventories | - | - | - | - | 236 | 0 | 1.653 | 1.659 | 0 | 88 |
| Receivables | - | - | - | - | 5.098 | 5.070 | 5.715 | 6.103 | 14.148 | 212 |
| Cash | - | - | - | - | 30.973 | 25.856 | 25.352 | 24.524 | 17.744 | 23.954 |
| Shareholders Funds | - | - | - | - | 32.385 | 72.510 | 77.393 | 95.949 | 90.795 | 75.900 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 3.921 | 7.510 | 2.112 | 4.157 | 2.592 | 3.386 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dacosmed Ana 2000 S.r.l.